SUBSTRATE CARRIERS FOR C-1(2)-DEHYDROGENATION OF 6-METHYLENE ANDROSTENEDIONE TO EXEMESTANE BY GROWING AND IMMOBILIZED ARTHROBACTER SIMPLEX NCIM 2449 by Patil, Prachi et al.
Vol 10, Issue 2, 2017
Online - 2455-3891 
Print - 0974-2441
SUBSTRATE CARRIERS FOR C-1(2)-DEHYDROGENATION OF 6-METHYLENE 
ANDROSTENEDIONE TO EXEMESTANE BY GROWING AND IMMOBILIZED ARTHROBACTER 
SIMPLEX NCIM 2449
PRACHI PATIL1*, RAJESH SHARMA1, TUSHAR BANERJEE2, SHRIDHAR PATIL2
1School of Pharmacy, Devi Ahilya University, Indore - 452 001, Madhya Pradesh, India. 2School of Life Sciences, Devi Ahilya University, 
Indore - 452001, Madhya Pradesh, India. Email: prachi2607@gmail.com
Received: 25 October 2016, Revised and Accepted: 14 November 2016
ABSTRACT
Objective: Permeability of hydrophobic steroid substrates across cell membrane is a critical factor during microbial bioconversion. To increase 
substrate intake, the feasibility of some organic solvents and emulsifiers as a substrate carrier on the bioconversion of 6-methylene androstenedione 
(6-MeAD) to exemestane was assessed.
Methods: AD, a commonly available steroid precursor, was chemically converted 6-MeAD. The time course of exemestane accumulation was estimated 
after addition of 6-MeAD dissolved in some organic solvents or dispersed with emulsifiers by growing and immobilized cells of Arthrobacter simplex 
NCIM 2449 in shake flask cultures.
Results: The use of substrate carriers for addition of 6-MeAD enhanced the bioconversion several folds. With growing bacterium in triplicate 
flasks, a peak mol % bioconversion recorded was- ethanol (67.25, 72 hrs); soybean oil + tween 80 (50.37, 48 hrs); acetone (38.84, 48 hrs); 
soybean oil (38.36, 48 hrs); lecithin (32.73, 48 hrs), methanol (32.71, 48 hrs) and tween 80 (10.37, 48 hrs). As compared to the growing cells, the 
bioconversion with Ca-alginate immobilized cells was delayed, and peak mol % bioconversion was recorded as ethanol (60.78, 120 hrs); soybean 
oil + tween 80 (42.98, 120 hrs); methanol (40.50, 72 hrs); soybean oil (38.36, 48 hrs); acetone (31.18, 72 hrs), and lecithin (33.67, 120 hrs); tween 
80 (13.87, 120 hrs).
Conclusion: The use of substrate carriers for addition of 6-MeAD increased the permeability of substrate and may be used to increase the yield of 
exemestane and reduce incubation time.
Keywords: Steroid substrate carrier, Exemestane, Arthrobacter simplex NCIM 2449, Breast cancer, Steroid C-1(2)-dehydrogenation, 3-ketosteroid-
delta-1-dehydrogenase.
INTRODUCTION
Exemestane (6-methylene androstadienedione [ADD]) is a suicidal 
aromatase inhibitor that lowers estrogen production in the body [1]. 
This drug is being used individually for the treatment of postmenopausal 
breast cancer patients [2] and under Phase III trial valuation in 
combination with bevacizumab [3]. Various schemes have been 
patented for chemical synthesis of exemestane depending on starting 
precursor such as androstenedione (AD) [4,5], boldenone [6], ADD [7], 
6-methylene AD (6-MeAD) [8], and testosterone [9]. However, the 
involvement of multiple steps, use of hazardous chemicals like selenium 
oxide and 2,3-dichloro-5,6-dicyano-1,4-benzoquinone required for the 
final step of C-1(2)-dehydrogenation and formation of extremely toxic 
hydrocyanic acid gas make these methods undesirable for the synthesis 
of exemestane. The sequence of reactions involved in the synthesis of 
exemestane from AD is presented in Fig. 1.
Alternative to the hazardous chemical reaction, biochemical reactions 
catalyzed by enzymes are preferred. Several microbial genera are 
known to secrete an enzyme 3-ketosteroid-Δ1-dehydrogenase (ksdD, 
EC 1.3.99.4), which catalyzes C-1(2)-dehydrogenation of a variety of 
steroid substrates. Arthrobacter simplex has been frequently used for 
C-1(2)-dehydrogenation of steroids substrates such as hydrocortisone 
to prednisolone [10,11] and 16-methyl Reichstein’s compound S-21 
acetate [12]. Resting cells of A. simplex have also been used for the 
bioconversion of 6-MeAD to exemestane in the presence of water 
immiscible organic solvent and an exogenous electron carrier [13]. 
Microbial C-1(2)-dehydrogenation of 6-MeAD to exemestane by 
Nocardioides simplex VKM Ac-2033D has also been reported,and the 
process is patented [14,15].
Aggregation of steroidal substrate particles pose major mass transfer 
problem that decreases the bioavailability of substrate during the 
bioconversion, and a variety of methods have been adopted to 
obtain finely dispersed suspension of the substrate in the medium. 
Frequently, steroidal substrates have been added in the form of their 
solution in water miscible organic carrier solvents such as ethanol, 
dimethylformamide, acetone, dimethylsulphoxide, and methanol 
[16-19]. However, this method has limitations imposed by the 
toxic effect of the carrier solvents on the microorganisms at higher 
concentrations.
Water-immiscible organic solvents have also been used in biphasic 
systems and the toxicity exerted by various organic solvents and 
solvent mixtures on steroid-1(2)-dehydrogenase activity of A. 
simplex have been worked out [20]. The use of natural oils as carriers 
yielded higher conversion of soybean sterols to 17-ketosteroids 
by mycobacteria [21,22]. Using lecithin and tween 80 as substrate 
dispersing agents, higher yields of ADD have been reported [23,24]. 
This work was carried out to assess the feasibility of some organic 
solvents and emulsifiers as dispersing agents to increase mass 
transfer of substrate so that an efficient and eco-friendly alternative 
for C-1(2)-dehydrogenation of 6-MeAD to exemestane can be 
developed.
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2017.v10i2.15861
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METHODS
Synthesis of 6-MeAD
AD procured from Jagsonpal Pharmaceuticals, New Delhi was 
converted to 6-MeAD following the method disclosed earlier [25] with 
suggested modification [26] as follows: 10 g of AD was dissolved in 
solvent mixture of 50 ml dioxane, 12 ml trimethylorthoformate and 
10 ml absolute ethyl alcohol, heated to 45°C on a magnetic stirrer 
and 0.6 g p-toluenesulfonic acid was added. After 1 hr, 4 ml N-methyl 
aniline and 4.5 ml formaldehyde (37%) were added, and the reaction 
was continued for 3 hrs at 50°C. The reaction solution was cooled to 
0°C, acidified by dropwise addition of 25 ml concentrated HCl and the 
reaction was continued further for 1 hr at 5°C. The reaction solution 
was diluted with 500 ml distilled water pre-cooled to 10°C, stirred for 
1 hr and the precipitated solids were filtered, washed with pre-cooled 
80 ml distilled water and vacuum dried. The dried precipitate was 
dissolved in 40 ml ethanol, decolorized with charcoal and crystallized 
from the filtrate. The crystalline product was dried under vacuum, 
weighed and subjected to thin layer chromatography (TLC), ultraviolet 
(UV), and infrared (IR) spectroscopic analyses.
Organism
Arthrobacter simplex NCIM 2449 was purchased from National 
Collection of Industrial Microorganisms, National Chemical Laboratory, 
Pune.
Bioconversion of 6-MeAD by growing cells
About 30 ml nutrient broth (pH 7.2) was dispensed in 150 ml capacity 
Erlenmeyer flask, and 30 mg 6-MeAD was dispersed with glass beads on 
a gyratory shaker (control). Alternatively, the substrate was dissolved in 
0.5 ml water soluble carrier (methanol/ethanol/acetone) and added to 
the medium with continuous stirring. When soybean oil was used as a 
carrier, 30 mg substrate was dissolved in 4.8 ml soybean oil or soybean 
oil containing 5 mg tween 80 and added to the medium. In case of 
lecithin (5 mg, hydrated with 1 ml distilled water) and tween 80 (5 mg), 
each of these ingredients was macerated with the 30 mg substrate in 
pestle and mortar and dispersed by addition of nutrient broth to make 
up the volume to 30 ml. After sterilization at 121°C for 15 minutes, the 
flasks were inoculated aseptically with 1 ml actively growing culture of 
A. simplex NCIM 2449 and incubated at 32±1°C on a gyratory incubator 
shaker (180 rpm, 2.5 mm eccentric throw).
Bioconversion of 6-MeAD by Ca-alginate immobilized cells
The method described by Kierstan and Bucke was adopted for 
immobilization of microbial biomass [27]. A. simplex NCIM 2449 was 
grown in four 500 ml capacity Erlenmeyer flasks, each containing 
100 ml nutrient broth adjusted to pH 7.3. After sterilization, the flasks 
were inoculated with actively growing culture of A. simplex NCIM 2449 
and incubated at 32±1°C on gyratory incubator shaker. After 72 hrs 
growth period, the biomass was aseptically harvested by centrifugation 
at 10,000 rpm for 10 minutes, washed twice with 0.85% saline and 
suspended in 200 ml sodium alginate solution. After thorough mixing 
on a cyclomixer, the alginate-biomass mixture was added dropwise 
through syringe into chilled 0.2 M calcium chloride solution. The beads 
were hardened overnight in 0.2 M calcium chloride solution at 4°C, 
washed with phosphate buffer (pH 7.0, 0.07 M) and stored in 0.02 M 
calcium chloride solution at 4°C in refrigerator. For bioconversion, 10 g 
beads were taken in 150 ml flasks containing 30 ml sterile phosphate 
buffer (pH 7.0, 0.07 M). The substrate 6-MeAD was added to the 
reaction buffer as described above replacing buffer in place of nutrient 
and incubated on a gyratory incubator shaker at 32±1°C. Samples of 
reaction buffer were taken after regular intervals and processed for 
qualitative and quantitative analyses.
TLC
The samples of the incubation medium or reaction buffer were drawn 
periodically and subjected to qualitative and quantitative analysis of 
exemestane. To 1 ml sample of medium in an eppendroff tube, 0.5 ml 
chloroform was added and thoroughly mixed on a cyclomixer. After 
centrifugation at 5000 rpm for 5 minutes, lower chloroform phase 
was transferred to another tube and dried over anhydrous sodium 
sulfate. 10 µl extract was spotted on pre-coated TLC plates (silica gel 60 
F254, Merck, Darmstadt) along with authentic sample of exemestane 
obtained from Cipla Ltd., Mumbai, India, and the plates were developed 
in benzene-ethyl acetate (5:2). The spots were visualized by spraying 
the plate with 50 % sulfuric acid followed by heating at 110°C for 
5 minutes. In the case of oil as carrier solvent, sample of incubation 
medium was centrifuged at 10,000 rpm for 10 minutes, 0.1 ml oil 
phase was transferred to another eppendroff tube, mixed thoroughly 
with 0.5 ml methanol on a cyclomixer, centrifuged at 10,000 rpm for 
10 minutes and upper methanolic phase was dried under vacuum. 
The residue was dissolved in 0.5 ml chloroform and subjected to TLC 
analysis as described above. Identification of exemestane spot on 
TLC plate was done by comparison of Rf value, color of the spot with 
authentic sample and spectroscopic methods.
Quantification of exemestane
Chloroform extract of the incubation medium (0.25 ml) was dried 
under vacuum, the residue was dissolved in 0.5 ml acetonitrile, filtered 
and 10 µl was subjected to high-performance liquid chromatography 
(HPLC) analysis as described earlier [28]. The specifications and the 
parameters of HPLC analysis were: Equipment JASCO Make, Model 1580; 
column: ODS HYPERSIL C 18 (250 mm × 4.6 mm); column temperature 
45°C; Detection wavelength 245 nm; mobile phase acetonitrile: water 
(60:40); flow rate 0.45 ml/min; total run time 20 minutes, injection 
volume 10 µl.
Bioconversion, isolation, and purification of exemestane
Bioconversion of 6-MeAD was carried out in six 500 ml capacity 
Erlenmeyer flasks, each containing 100 ml nutrient broth. Substrate 100 
mg dissolved in 2 ml ethanol was added in each flask with continuous 
stirring, sterilized and inoculated with 5 ml actively growing culture 
of A. simplex NCIM 2449. After 96 hrs incubation on gyratory shaker, 
the fermentation broth of all flasks was combined and extracted with 
3 ml × 100 ml chloroform. The chloroform extract was dried over 
anhydrous sodium sulfate and chloroform was recovered in rotary 
flash evaporator. The obtained residue was dissolved in ethyl acetate, 
decolorized with charcoal; the filtrate was concentrated to 30 ml and 
cooled to 4°C in refrigerator for crystallization. Crystals separated after 
overnight cooling were collected by filtration, washed with chilled ethyl 
acetate and dried under vacuum.
Fig. 1: Sequence of reactions involved in the synthesis of exemestane from androstenedione.
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RESULTS
Identification of product of chemical synthesis
10 g of AD taken for chemical synthesis yielded 7.136 g of crystalline 
product, which was identified as 6-MeAD on the basis of following 
characteristics:
• Color of spot on TLC plate: Bluish green; Rf - 0.46 (Fig. 2a)
• UV absorption spectrum: λmax 261.4 nm (Fig. 2b)
• IR spectrum (KBr): Peaks, cm−1 at 3832.3, 3793.7 (6-CH2), (17-C=O); 
1454.2 and 1334.6 (Δ4-3-C=O).
• The molar yield of 6-MeAD was 68.48 mol %.
Identification of bioconversion product
A total of 500 mg 6-MeAD was added in five bioconversion flasks and 
yielded 245 mg crystalline product. The product was identified as 
exemestane on the basis of following characteristics:
• Color of spot on co-TLC plate: Reddish pink; Rf - 0.40 (Fig. 2a)
• UV absorption spectrum: λmax 245.5 nm (Fig. 2c)
• The molar yield of exemestane was 49.33 mol %.
HPLC analysis of crystalline bioconversion product indicated a single 
peak (Fig. 3) at average retention time (6 runs) at 11.67±0.28 minutes 
(mean±standard deviation). A fairly proportional relationship was 
observed between exemestane concentration (2.5, 5.0, 7.5 and 10.0 
µg/ml) and peak area (r2=0.9855) and was used for quantification of 
exemestane formed during the bioconversion.
Mole % bioconversion of 6-MeAD to exemestane by growing cells of 
A. simplex NCIM 2449 with different carriers is presented in Table 1. 
In the case of control and tween 80, no exemestane was detected in the 
medium at 24 h incubation period, whereas a rapid accumulation of 
exemestane was recorded with other carriers. As compared to control, 
the use of all other substrate carriers increased C-1(2)-dehydrogenation 
activity of A. simplex NCIM 2449. Peak bioconversion was recorded 
Table 1: Mol % bioconversion of 6-MeAD to exemestane by growing cells of A. simplex NCIM 2449
Substrate carrier Mol % bioconversion±SD after incubation period (hrs)
24 48 72 96 120
Control nd nd 3.45±0.30 7.45±0.32 15.07±0.45
Methanol 31.53±1.81 32.71±2.05 20.53±0.93 18.31±1.13 16.10±0.09
Ethanol 29.45±2.30 55.6±2.05 67.25±3.04 63.19±2.96 60.68±0.36
Acetone 25.88±1.90 38.84±1.62 25.31±1.87 23.67±1.33 23.32±1.26
Soybean oil 34.52±1.63 38.36±1.92 24.22±1.75 20.14±1.52 18.73±0.98
Soybean oil+tween 80 38.97±2.02 50.37±2.21 32.62±2.30 28.44±1.56 28.02±1.44
Tween 80 nd 10.37±1.69 6.90±0.64 3.42±0.44 4.09±0.56
Lecithin 30.11±2.14 32.73±1.70 21.84±1.91 21.27±1.49 18.55±1.52
SD: Standard deviation (N=3), nd: Not detected, A. simplex: Arthrobacter simplex, 6-MeAD: 6-methylene androstenedione, NCIM: National Collection of Industrial 
Microorganisms
Table 2: Mol % conversion of 6-MeAD to exemestane by Ca-alginate immobilized cells of A. simplex NCIM 2449
Substrate carrier Mol % bioconversion±SD after incubation period (hrs)
24 48 72 96 120
Control nd nd nd  2.65±0.34 8.60±0.50
Methanol 18.46±0.91 38.78±1.84 40.50±1.79 36.85±1.97 35.88±1.50
Ethanol 19.53±1.34 36.55±3.06 56.39±3.14 57.29±3.40 60.78±2.97
Acetone 14.18±1.12 17.27±1.42 31.18±1.76 29.54±1.43 30.13±1.33
Soybean oil 34.52±1.63 38.36±1.92 24.22±1.75 20.14±1.52 18.74±0.97
Soybean oil+tween 80 12.05±1.04 25.40±1.97 40.11±3.78 40.32±3.17 42.98±2.02
Tween 80 nd nd 8.36±0.96 12.54±0.87 13.87±1.05
Lecithin 15.32±0.73 21.61±1.13 25.89±1.83 28.12±2.11 33.67±2.88
SD: Standard deviation (N=3), nd: Not detected, A. simplex: Arthrobacter simplex, NCIM: National Collection of Industrial Microorganisms
Fig. 2: Thin layer chromatography scan (a) and ultraviolet absorption spectra of 6-methylene androstenedione (b) and exemestane (c)
a b c
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at 48 hrs incubation period with exception of ethanol as a substrate 
carrier, which was observed at 72 hrs. A decline in the exemestane 
content of the medium was observed after reaching a peak, indicating 
the degradation of this compound by A. simplex NCIM 2449.
Table 2 shows the mol % conversion of 6-MeAD to exemestane by 
Ca-alginate immobilized cells of A. simplex NCIM 2449. Although the 
overall bioconversion indicated similar pattern as observed with 
growing cells, a delay in peak bioconversion was noted. Among various 
carriers used, the highest bioconversion was recorded again with 
ethanol as a substrate carrier till the end of incubation period at 120 
hrs, indicating the suitability of ethanol for 1(2)- dehydrogenation 
activity of Ca- alginate immobilized cells of A. simplex NCIM 2449.
DISCUSSION
Permeability of hydrophobic steroid substrate across bacterial cell 
membrane plays a key role in bioconversion catalyzed by enzymes 
present inside the bacterial cell. The data obtained during this 
work clearly indicated an enhanced bioconversion when 6-MeAD 
was added in dissolved form in organic solvents or dispersed with 
emulsifiers. The enhancement in the bioconversion activity of 
A. simplex in the presence of organic solvents has been attributed to 
increased permeability of cell membrane to steroidal substrates [29]. 
The analysis of cell membrane of A. simplex grown in the presence of 
ethanol revealed an increment in cis-isomers of unsaturated fatty acids, 
thereby disorganization of native arrangement, resulting in increased 
permeability to steroid substrates [16]. In another study, reduction in 
the unsaturated and long chain fatty acids of A. simplex membrane in 
the presence of hydroxypropyl-β-cyclodextrin has been reported [30]. 
This study indicated that the organic solvents, soybean oil and lecithin 
increased the permeability of 6-MeAD, and resulted in early and higher 
bioconversion. Tween 80 alone proved deleterious to the bioconversion 
but favored the process when added along with soybean oil. It can 
be concluded that this anionic detergent lysed A. simplex cells at 
5 mg/30 ml concentration when used alone. Similar observation was 
recorded during 9α-steroid hydroxylation by Rhodococcus sp. [31]. In 
comparison with the earlier reports of bioconversion of 6-MeAD to 
exemestane by A. simplex in xylene-water two-phase system [32] and 
β-cyclodextrin complexation technique [33], higher bioconversion was 
achieved in the present work.
The stability of C-1(2)-dehydrogenase activity of A. simplex cells 
immobilized in Ca-polygalacturonate [34], Ca- alginate [35], 
k-carrageenan beads, and polyurethane foam [36] has been shown 
against a variety of steroid substrates. The present work indicated 
the use of growing and Ca-alginate immobilized A. simplex cells as an 
environment-friendly alternative for 1(2)-dehydrogenation of 6-MeAD 
to exemestane.
Since exemestane is degraded simultaneously along with its formation 
both by growing as well as Ca-alginate immobilized cells of A. simplex 
NCIM 2449, the amount of exemestane accumulated in the fermentation 
broth is a result of rate of its formation and degradation. Therefore, 
precise termination of bioconversion reaction is suggested to harvest 
maximum product.
CONCLUSION
C-1(2)-dehydrogenase activity of growing and Ca-alginate immobilized 
A. simplex NCIM 2449 cells can be exploited for the bioconversion of 
6-MeAD to exemestane. To overcome the steroid permeability barrier, 
6-MeAD may be dispersed in the incubation medium using ethanol 
as substrate carrier. This organism and the described process may be 
scaled up to replace the hazardous chemical reaction by eco-friendly 
microbial bioconversion.
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